Cost-ineffectiveness of serum vancomycin levels

Eur J Clin Microbiol Infect Dis. 2007 Jul;26(7):509-11. doi: 10.1007/s10096-007-0314-4.
No abstract available

MeSH terms

  • Cost-Benefit Analysis
  • Creatinine / blood
  • Drug Monitoring / economics*
  • Hospitals, University
  • Humans
  • Retrospective Studies
  • Vancomycin / blood*

Substances

  • Vancomycin
  • Creatinine